Author:
Małecki Michał,Domański Maciej,Ciechanowski Kazimierz
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Soro L, Bartus C, Burcell S.J. Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies. Clin Aesthet Dermatol 2015;8(5):41-46. Review.
2. Hon KL, Li JJ, Cheng BL, Luk DC, Murrell DF, Choi PC, et al. Age and etiology of childhood epidermolysis bullosa mortality. J Dermatol Treat. 2015;26(2):178–82.
3. Yuen WY, Jonkman MF. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol. 2011;65(4):780–9. doi:
10.1016/j.jaad.2010.07.006
. Epub 2011 May 31
4. Larcher F, Del Río M. Innovative therapeutic strategies for recessive dystrophic Epidermolysis Bullosa. Actas Dermosifiliogr. 2015;106(5):376–82.
5. Woo HJ, Lee JH, Kim SC, Kim CW, Kim TY. Generalized atrophic benign epidermolysis bullosa--poor prognosis associated with chronic renal failure. Clin Exp Dermatol. 2000;25(3):212-4.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献